Imunon, Inc. Legal Fees
Imunon, Inc. (IMNN) reported Legal Fees of $583.50 thousand for the 0-month period ending 2023-04-19, per its 10-Q filed 2023-08-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:LegalFees · last filed 2023-08-10
- 2023-04-19: Legal Fees 0 month $583.50K.
- 2013-02-25: Legal Fees 1 month $50.00K.
| Period end | Legal Fees 0 month | Legal Fees 1 month |
|---|---|---|
| 2023-04-19 | $583.50K 10-Q · filed 2023-08-10 | |
| 2013-02-25 | $50.00K 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |